The mice model market is projected to reach USD 2.74 billion by 2030 from USD 1.70 billion in 2025, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by several factors, such as rising adoption of mice models in preclinical studies due to genetic & physiological versatility; the increasing demand for mouse clinical trials (MCTs); the rising demand for personalized medicine in oncology; and advancements in genetic engineering. Utilization of CRISPR in biomedical research and the increasing demand for disease-specific models are also expected to contribute to market growth during the forecast period.
By model type, the inbred mice segment accounted for the largest share of the market in 2024.
The market is segmented by model type into inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice. In 2024, the inbred mice segment accounted for the largest share of the mice model market. The large share of the inbred mice segment is attributed to the ability of inbred strains to provide genetic uniformity for preclinical studies, standardized breeding protocols that enable scalable production, and supply chains that support continuous availability. Regulatory frameworks at national and international levels recognize inbred strains as reference models for efficacy and safety assessment, and centralized breeding facilities implement quality control measures to maintain strain integrity. Adoption of inbred mice spans pharmaceutical and biotechnology companies and academic and government research institutions, where controlled genetic backgrounds reduce experimental variability.
By application, the drug discovery & development segment accounted for the largest share of the market in 2024.
The mice model market is segmented into drug discovery & development, research applications, and personalized medicine. In 2024, the drug discovery & development segment accounted for the largest share of the market. Mouse models are deployed in target validation assays to confirm the relevance of molecular targets, in lead optimization studies to compare pharmacodynamic profiles, and in efficacy evaluations to measure treatment responses under controlled conditions. Safety pharmacology protocols—cardiovascular, respiratory, and central nervous system endpoints—rely on telemetry recordings and behavioral assays conducted in mice. At the same time, reproductive and developmental toxicity assessments use timed-pregnancy protocols to determine embryonic viability and teratogenic risk. Histopathological examinations and clinical chemistry analyses of tissue samples support regulatory submissions, and omics profiling (transcriptomics, proteomics, metabolomics) informs dose selection and mechanism-of-action studies. Service providers integrate these applications into end-to-end workflows for end users. Combined, these integrated applications ensure the dominance of drug discovery & development applications in the mice model market.
By region, North America accounted for the largest share of the mice model market in 2024.
In 2024, North America accounted for the largest share of the mice model market due to the concentration of major contract research organizations and breeding suppliers, government and private funding mechanisms, and a regulatory environment emphasizing standardized preclinical practices. The key market players, such as Charles River Laboratories (US), The Jackson Laboratory (US), and Inotiv (US), have their presence in the region, thus ensuring regional supply and technical support. Public funding agencies such as the National Institutes of Health (NIH) allocate substantial budgets to basic & translational research, while pharmaceutical & biotechnology companies commit a significant portion of R&D expenditure to preclinical in vivo models. Academic research institutions and specialized contract research organizations leverage this infrastructure and funding landscape to conduct target validation, toxicology, and efficacy studies, reinforcing North America’s large share in the global mice model market.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Tier 1-25%, Tier 2-35%, and Tier 3- 40%
• By Designation: C-level Executives - 55%, Directors- 20%, and Others- 25%
• By Region: North America -45%, Europe - 20%, the Asia Pacific -20%, Latin America -10%, the Middle East- 3%, and Africa-2%
Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), Biocytogen (China), TRANS GENIC INC. (Japan) Harbour BioMed (China), genOway (France), GemPharmatech (China), Cyagen (US), Ozgene Pty Ltd (Australia), Taconic Biosciences, Inc. (US), TransCure bioServices (France), Vivo Bio Tech Ltd (India), ingenious targeting laboratory (US), Janvier Labs (France), Champions Oncology, Inc (US), and Vitalstar Biotechnology Co., Ltd. (China) are some of the key companies offering mice model products & services.
Research Coverage:
This research report categorizes the mice model market by model type & service [model types (inbred mice, genetically engineered mice, hybrid/congenic mice, and outbred mice, breeding services, cryopreservation services, rederivation services, quarantine services, and other services)], by application (drug discovery & development, research applications, and personalized medicine), by technology (CRISPR/Cas9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies), by therapeutic area (oncology, neurology, immunology, metabolic diseases, cardiovascular diseases, and other therapeutic areas), by product end user (pharmaceutical & biotechnology companies, academic & research Institutes, and CROs & CDMOs), by services end user (pharmaceutical & biotechnology companies, government & biomedical research institutes, and CDMOs), and by region (North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa).
The report's scope covers detailed information regarding the primary factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the mice model market. A thorough analysis of the key industry players has been conducted to provide insights into their business overview, solutions, and services; key strategies; new product & service launches, acquisitions, and recent developments associated with the mice model market. This report covers the competitive analysis of upcoming startups in the mice model market ecosystem.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the mice model market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide information on the key market drivers, restraints, challenges, trends, and opportunities.
The report provides insights on the following :
• Analysis of key drivers (high adoption of mice models in preclinical studies, the increasing demand for mouse clinical trials, the rising demand for personalized medicine in oncology, technological advancements in genetic engineering), restrains (the introduction of 3D printed models, ethical concerns, and regulatory restrictions), opportunities (Utilization of CRISPR in biomedical research, and the rising demand for disease-specific models), and challenges (development of alternative animal testing methods and genetic & phenotypic variability).
• Product approvals: Detailed insights into newly approved products of the mice models market.
• Market development: Comprehensive information about lucrative markets – the report analyses the mice model market across varied regions.
• Market diversification: Exhaustive information about new products, recent developments, and investments in the mice model market.
• Pipeline analysis: Comprehensive information about products under clinical trials.
• Competitive assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Charles River Laboratories (US), Inotiv (US), THE JACKSON LABORATORY (US), JSR Corporation (Japan), and Biocytogen (China).
圖表清單 List of Tables & Figures
TABLE 1 MICE MODEL MARKET: IMPACT ANALYSIS 55
TABLE 2 MICE MODEL MARKET: RISK ASSESSMENT ANALYSIS 55
TABLE 3 MICE MODEL MARKET: IMPACT ANALYSIS 64
TABLE 4 AVERAGE SELLING PRICE TREND OF MODEL TYPES, BY KEY PLAYER, 20222−2024 76
TABLE 5 AVERAGE SELLING PRICE OF MODEL TYPES, BY REGION, 2024 78
TABLE 6 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY VENDORS 80
TABLE 7 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY SERVICE VENDOR 80
TABLE 8 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY END USER 81
TABLE 9 MICE MODEL MARKET: ROLE IN ECOSYSTEM, BY REGULATORY ORGANIZATION 81
TABLE 10 PATENTS FILED, BY DOCUMENT TYPE, 2014−2024 87
TABLE 11 PATENTS IN MICE MODELS MARKET 89
TABLE 12 IMPORT VALUE OF HS CODE 106.19.90–COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020−2024 (USD THOUSANDS) 89
TABLE 13 IMPORT VALUE OF HS CODE 106.19.90−COMPLIANT PRODUCTS FOR TOP 20 COUNTRIES, 2020−2024 (USD THOUSANDS) 90
TABLE 14 MICE MODEL MARKET: CONFERENCES & EVENTS (2025–2026) 91
TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93
TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94
TABLE 18 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
TABLE 19 MICE MODEL MARKET: REGULATORY SCENARIO 95
TABLE 20 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 103
TABLE 21 INVESTMENT & FUNDING ACTIVITIES, BY KEY PLAYER, 2022−2025 107
TABLE 22 US-ADJUSTED RECIPROCAL TARIFF RATES 110
TABLE 23 KEY PRODUCT-RELATED TARIFFS: LIVE ANIMALS, PRODUCT OF ANIMAL ORIGIN, AND MISCELLANEOUS CHEMICAL PRODUCTS 111
TABLE 24 CRITICAL COMPONENTS EXPOSED TO TARIFF CHANGES 112
TABLE 25 MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 116
TABLE 26 MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 116
TABLE 27 NORTH AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 28 EUROPE: MICE MODEL TYPE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117
TABLE 29 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 117
TABLE 30 LATIN AMERICA: MICE MODEL TYPE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 31 MIDDLE EAST: MICE MODEL TYPE MARKET, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 32 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 33 MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 119
TABLE 34 INBRED MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 35 NORTH AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 36 EUROPE: INBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 37 ASIA PACIFIC: INBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 38 LATIN AMERICA: INBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 39 MIDDLE EAST: INBRED MICE MODEL MARKET, BY REGION,
2023–2030 (USD MILLION) 121
TABLE 40 GCC COUNTRIES: INBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 41 GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 42 NORTH AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 123
TABLE 43 EUROPE: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 123
TABLE 44 ASIA PACIFIC: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 45 LATIN AMERICA: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 46 MIDDLE EAST: GENETICALLY ENGINEERED MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 47 GCC COUNTRIES: GENETICALLY ENGINEERED MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125
TABLE 48 HYBRID/CONGENIC MICE MODEL MARKET, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 49 NORTH AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 50 EUROPE: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 51 ASIA PACIFIC: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 52 LATIN AMERICA: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 127
TABLE 53 MIDDLE EAST: HYBRID/CONGENIC MICE MODEL MARKET, BY REGION,
2023–2030 (USD MILLION) 127
TABLE 54 GCC COUNTRIES: HYBRID/CONGENIC MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 128
TABLE 55 OUTBRED MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 56 NORTH AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 57 EUROPE: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 58 ASIA PACIFIC: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 129
TABLE 59 LATIN AMERICA: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 130
TABLE 60 MIDDLE EAST: OUTBRED MICE MODEL MARKET, BY REGION,
2023–2030 (USD MILLION) 130
TABLE 61 GCC COUNTRIES: OUTBRED MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 130
TABLE 62 MICE MODEL SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 131
TABLE 63 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 64 EUROPE: MICE MODEL SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 132
TABLE 65 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 132
TABLE 66 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 132
TABLE 67 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 133
TABLE 68 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 133
TABLE 69 MICE MODEL SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 133
TABLE 70 MICE MODEL BREEDING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 71 NORTH AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 72 EUROPE: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 73 ASIA PACIFIC: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 74 LATIN AMERICA: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 75 MIDDLE EAST: MICE MODEL BREEDING SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 76 GCC COUNTRIES: MICE MODEL BREEDING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136
TABLE 77 MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 137
TABLE 78 NORTH AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 79 EUROPE: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 80 ASIA PACIFIC: MICE MODEL CRYOPRESERVATION SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 81 LATIN AMERICA: MICE MODEL CRYOPRESERVATION SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 139
TABLE 82 MIDDLE EAST: MICE MODEL CRYOPRESERVATION SERVICES MARKET, BY REGION 2023–2030 (USD MILLION) 139
TABLE 83 GCC COUNTRIES: MICE MODEL CRYOPRESERVATION SERVICES MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 140
TABLE 84 MICE MODEL REDERIVATION SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 141
TABLE 85 NORTH AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 86 EUROPE: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 87 ASIA PACIFIC: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 88 LATIN AMERICA: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142
TABLE 89 MIDDLE EAST: MICE MODEL REDERIVATION SERVICES, BY COUNTRY,
2023–2030 (USD MILLION) 142
TABLE 90 GCC COUNTRIES: MICE MODEL REDERIVATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143
TABLE 91 MICE MODEL QUARANTINE SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 144
TABLE 92 NORTH AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144
TABLE 93 EUROPE: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 144
TABLE 94 ASIA PACIFIC: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 145
TABLE 95 LATIN AMERICA: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 96 MIDDLE EAST: MICE MODEL QUARANTINE SERVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 97 GCC COUNTRIES: MICE MODEL QUARANTINE SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146
TABLE 98 MICE MODEL MARKET FOR OTHER SERVICES, BY REGION,
2023–2030 (USD MILLION) 147
TABLE 99 NORTH AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 147
TABLE 100 EUROPE: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY,
2023–2030 (USD MILLION) 147
TABLE 101 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY,
2023–2030 (USD MILLION) 148
TABLE 102 LATIN AMERICA: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 148
TABLE 103 MIDDLE EAST: MICE MODEL MARKET FOR OTHER SERVICES, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 104 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER SERVICES, BY COUNTRY, 2023–2030 (USD MILLION) 149
TABLE 105 MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 151
TABLE 106 MICE MODEL MARKET FOR CRISPR/CAS9, BY REGION,
2023–2030 (USD MILLION) 152
TABLE 107 NORTH AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY,
2023–2030 (USD MILLION) 152
TABLE 108 EUROPE: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 109 ASIA PACIFIC: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY,
2023–2030 (USD MILLION) 153
TABLE 110 LATIN AMERICA: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY,
2023–2030 (USD MILLION) 154
TABLE 111 MIDDLE EAST: MICE MODEL MARKET FOR CRISPR/CAS9, BY REGION,
2023–2030 (USD MILLION) 154
TABLE 112 GCC COUNTRIES: MICE MODEL MARKET FOR CRISPR/CAS9, BY COUNTRY,
2023–2030 (USD MILLION) 154
TABLE 113 MICE MODEL MARKET FOR MICROINJECTIONS, BY REGION,
2023–2030 (USD MILLION) 155
TABLE 114 NORTH AMERICA: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 156
TABLE 115 EUROPE: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY,
2023–2030 (USD MILLION) 156
TABLE 116 ASIA PACIFIC: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY,
2023–2030 (USD MILLION) 156
TABLE 117 LATIN AMERICA: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 118 MIDDLE EAST: MICE MODEL MARKET FOR MICROINJECTIONS, BY REGION,
2023–2030 (USD MILLION) 157
TABLE 119 GCC COUNTRIES: MICE MODEL MARKET FOR MICROINJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 157
TABLE 120 MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY REGION, 2023–2030 (USD MILLION) 158
TABLE 121 NORTH AMERICA: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 122 EUROPE: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 123 ASIA PACIFIC: MICE MODEL MARKET FOR EMBRYONIC STEM CELL INJECTIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 159
TABLE 124 LATIN AMERICA: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 125 MIDDLE EAST: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 126 GCC COUNTRIES: MICE MODELS MARKET FOR EMBRYONIC STEM CELL INJECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 160
TABLE 127 MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE, BY REGION,
2023–2030 (USD MILLION) 161
TABLE 128 NORTH AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 129 EUROPE: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 130 ASIA PACIFIC: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY COUNTRY, 2023–2030 (USD MILLION) 162
TABLE 131 LATIN AMERICA: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 132 MIDDLE EAST: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY REGION, 2023–2030 (USD MILLION) 163
TABLE 133 GCC COUNTRIES: MICE MODEL MARKET FOR NUCLEAR TRANSFER TECHNIQUE,
BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 134 MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2023–2030 (USD MILLION) 164
TABLE 135 NORTH AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 136 EUROPE: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY,
2023–2030 (USD MILLION) 165
TABLE 137 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 165
TABLE 138 LATIN AMERICA: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 139 MIDDLE EAST: MICE MODEL MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 166
TABLE 140 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 141 MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 168
TABLE 142 MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 169
TABLE 143 NORTH AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 169
TABLE 144 EUROPE: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 145 ASIA PACIFIC: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY COUNTRY, 2023–2030 (USD MILLION) 170
TABLE 146 LATIN AMERICA: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 147 MIDDLE EAST: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT,
BY REGION, 2023–2030 (USD MILLION) 171
TABLE 148 GCC COUNTRIES: MICE MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 171
TABLE 149 MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 173
TABLE 150 NORTH AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 151 EUROPE: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 173
TABLE 152 ASIA PACIFIC: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 153 LATIN AMERICA: MICE MODEL MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 174
TABLE 154 MIDDLE EAST: MICE MODEL MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 174
TABLE 155 GCC COUNTRIES: MICE MODEL MARKET FOR RESEARCH APPLICATIONS,
BY COUNTRY, 2023–2030 (USD MILLION) 175
TABLE 156 MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION,
2023–2030 (USD MILLION) 176
TABLE 157 NORTH AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 158 EUROPE: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 176
TABLE 159 ASIA PACIFIC: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 160 LATIN AMERICA: MICE MODEL MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2023–2030 (USD MILLION) 177
TABLE 161 MIDDLE EAST: MICE MODEL MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2023–2030 (USD MILLION) 177
TABLE 162 GCC COUNTRIES: MICE MODEL MARKET FOR PERSONALIZED MEDICINE,
BY COUNTRY, 2023–2030 (USD MILLION) 178
TABLE 163 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 180
TABLE 164 MICE MODEL MARKET FOR ONCOLOGY, BY REGION, 2023–2030 (USD MILLION) 181
TABLE 165 NORTH AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 181
TABLE 166 EUROPE: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 182
TABLE 167 ASIA PACIFIC: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 182
TABLE 168 LATIN AMERICA: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 183
TABLE 169 MIDDLE EAST: MICE MODEL MARKET FOR ONCOLOGY, BY REGION,
2023–2030 (USD MILLION) 183
TABLE 170 GCC COUNTRIES: MICE MODEL MARKET FOR ONCOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 183
TABLE 171 MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION,
2023–2030 (USD MILLION) 184
TABLE 172 NORTH AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 173 EUROPE: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY,
2023–2030 (USD MILLION) 185
TABLE 174 ASIA PACIFIC: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 185
TABLE 175 LATIN AMERICA: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 176 MIDDLE EAST: MICE MODEL MARKET FOR METABOLIC DISEASES, BY REGION, 2023–2030 (USD MILLION) 186
TABLE 177 GCC COUNTRIES: MICE MODEL MARKET FOR METABOLIC DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 186
TABLE 178 MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION,
2023–2030 (USD MILLION) 187
TABLE 179 NORTH AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 180 EUROPE: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 181 ASIA PACIFIC: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 188
TABLE 182 LATIN AMERICA: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 189
TABLE 183 MIDDLE EAST: MICE MODEL MARKET FOR IMMUNOLOGY, BY REGION,
2023–2030 (USD MILLION) 189
TABLE 184 GCC COUNTRIES: MICE MODEL MARKET FOR IMMUNOLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 189
TABLE 185 MICE MODEL MARKET FOR NEUROLOGY, BY REGION, 2023–2030 (USD MILLION) 190
TABLE 186 NORTH AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 187 EUROPE: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 188 ASIA PACIFIC: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 189 LATIN AMERICA: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 192
TABLE 190 MIDDLE EAST: MICE MODEL MARKET FOR NEUROLOGY, BY REGION,
2023–2030 (USD MILLION) 192
TABLE 191 GCC COUNTRIES: MICE MODEL MARKET FOR NEUROLOGY, BY COUNTRY,
2023–2030 (USD MILLION) 192
TABLE 192 MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY REGION,
2023–2030 (USD MILLION) 193
TABLE 193 NORTH AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 194 EUROPE: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 195 ASIA PACIFIC: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 194
TABLE 196 LATIN AMERICA: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 195
TABLE 197 MIDDLE EAST: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES,
BY REGION, 2023–2030 (USD MILLION) 195
TABLE 198 GCC COUNTRIES: MICE MODEL MARKET FOR CARDIOVASCULAR DISEASES,
BY COUNTRY, 2023–2030 (USD MILLION) 195
TABLE 199 MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION,
2023–2030 (USD MILLION) 197
TABLE 200 NORTH AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS,
BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 201 EUROPE: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2023–2030 (USD MILLION) 197
TABLE 202 ASIA PACIFIC: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS,
BY COUNTRY, 2023–2030 (USD MILLION) 198
TABLE 203 LATIN AMERICA: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS,
BY COUNTRY, 2023–2030 (USD MILLION) 198
TABLE 204 MIDDLE EAST: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS,
BY REGION, 2023–2030 (USD MILLION) 198
TABLE 205 GCC COUNTRIES: MICE MODEL MARKET FOR OTHER THERAPEUTIC AREAS,
BY COUNTRY, 2023–2030 (USD MILLION) 199
TABLE 206 MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 201
TABLE 207 MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 202
TABLE 208 NORTH AMERICA: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 202
TABLE 209 EUROPE: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 210 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 203
TABLE 211 LATIN AMERICA: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 204
TABLE 212 MIDDLE EAST: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 204
TABLE 213 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 204
TABLE 214 MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY REGION,
2023–2030 (USD MILLION) 205
TABLE 215 NORTH AMERICA: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 206
TABLE 216 EUROPE: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY,
2023–2030 (USD MILLION) 206
TABLE 217 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 206
TABLE 218 LATIN AMERICA: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 USD MILLION) 207
TABLE 219 MIDDLE EAST: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY REGION, 2023–2030 (USD MILLION) 207
TABLE 220 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR CROS & CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 207
TABLE 221 MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 208
TABLE 222 NORTH AMERICA: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 209
TABLE 223 EUROPE: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 209
TABLE 224 ASIA PACIFIC: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 209
TABLE 225 LATIN AMERICA: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 210
TABLE 226 MIDDLE EAST: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 210
TABLE 227 GCC COUNTRIES: MICE MODEL TYPE MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 210
TABLE 228 MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 212
TABLE 229 MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 213
TABLE 230 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 213
TABLE 231 EUROPE: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 213
TABLE 232 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 214
TABLE 233 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 214
TABLE 234 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 214
TABLE 235 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 215
TABLE 236 MICE MODEL SERVICES MARKET FOR CDMOS, BY REGION,
2023–2030 (USD MILLION) 216
TABLE 237 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 216
TABLE 238 EUROPE: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY,
2023–2030 (USD MILLION) 216
TABLE 239 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY,
2023–2030 (USD MILLION) 217
TABLE 240 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023–2030 USD MILLION) 217
TABLE 241 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR CDMOS, BY REGION,
2023–2030 (USD MILLION) 217
TABLE 242 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR CDMOS, BY COUNTRY, 2023–2030 (USD MILLION) 218
TABLE 243 MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 219
TABLE 244 NORTH AMERICA: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 219
TABLE 245 EUROPE: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 219
TABLE 246 ASIA PACIFIC: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 220
TABLE 247 LATIN AMERICA: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 220
TABLE 248 MIDDLE EAST: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 220
TABLE 249 GCC COUNTRIES: MICE MODEL SERVICES MARKET FOR GOVERNMENT & BIOMEDICAL RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 221
TABLE 250 MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 223
TABLE 251 NORTH AMERICA: MACROECONOMIC INDICATORS 224
TABLE 252 NORTH AMERICA: MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 225
TABLE 253 NORTH AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 226
TABLE 254 NORTH AMERICA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 226
TABLE 255 NORTH AMERICA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 226
TABLE 256 NORTH AMERICA: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 227
TABLE 257 NORTH AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 227
TABLE 258 NORTH AMERICA: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 227
TABLE 259 NORTH AMERICA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 228
TABLE 260 NORTH AMERICA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 228
TABLE 261 US: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 229
TABLE 262 US: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 230
TABLE 263 US: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 230
TABLE 264 US: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 230
TABLE 265 US: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 231
TABLE 266 US: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 231
TABLE 267 US: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 231
TABLE 268 US: MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION 232
TABLE 269 CANADA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 233
TABLE 270 CANADA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 233
TABLE 271 CANADA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 233
TABLE 272 CANADA: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 234
TABLE 273 CANADA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 234
TABLE 274 CANADA: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 234
TABLE 275 CANADA: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 235
TABLE 276 CANADA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 235
TABLE 277 EUROPE: MACROECONOMIC INDICATORS 236
TABLE 278 EUROPE: MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237
TABLE 279 EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 237
TABLE 280 EUROPE: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 237
TABLE 281 EUROPE: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 238
TABLE 282 EUROPE: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 238
TABLE 283 EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 238
TABLE 284 EUROPE: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 239
TABLE 285 EUROPE: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 239
TABLE 286 EUROPE: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 239
TABLE 287 GERMANY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 240
TABLE 288 GERMANY: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 241
TABLE 289 GERMANY: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 241
TABLE 290 GERMANY: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 241
TABLE 291 GERMANY: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 242
TABLE 292 GERMANY: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 242
TABLE 293 GERMANY: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 242
TABLE 294 GERMANY: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 243
TABLE 295 UK: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 243
TABLE 296 UK: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 244
TABLE 297 UK: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 244
TABLE 298 UK: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 244
TABLE 299 UK: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 245
TABLE 300 UK: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245
TABLE 301 UK: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 245
TABLE 302 UK: MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION 246
TABLE 303 FRANCE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 246
TABLE 304 FRANCE: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 247
TABLE 305 FRANCE: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 247
TABLE 306 FRANCE: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 247
TABLE 307 FRANCE: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 248
TABLE 308 FRANCE: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 248
TABLE 309 FRANCE: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 248
TABLE 310 FRANCE: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 249
TABLE 311 ITALY: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 250
TABLE 312 ITALY: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 250
TABLE 313 ITALY: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 250
TABLE 314 ITALY: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 251
TABLE 315 ITALY: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 251
TABLE 316 ITALY: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 251
TABLE 317 ITALY: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 252
TABLE 318 ITALY: MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION 252
TABLE 319 SPAIN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 253
TABLE 320 SPAIN: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 253
TABLE 321 SPAIN: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 254
TABLE 322 SPAIN: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 254
TABLE 323 SPAIN: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 254
TABLE 324 SPAIN: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 255
TABLE 325 SPAIN: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 255
TABLE 326 SPAIN: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 255
TABLE 327 REST OF EUROPE: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 256
TABLE 328 REST OF EUROPE: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 257
TABLE 329 REST OF EUROPE: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 257
TABLE 330 REST OF EUROPE: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 257
TABLE 331 REST OF EUROPE: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 258
TABLE 332 REST OF EUROPE: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 258
TABLE 333 REST OF EUROPE: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 258
TABLE 334 REST OF EUROPE: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 259
TABLE 335 ASIA PACIFIC: MACROECONOMIC INDICATORS 260
TABLE 336 ASIA PACIFIC: MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 262
TABLE 337 ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 262
TABLE 338 ASIA PACIFIC: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 262
TABLE 339 ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 263
TABLE 340 ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 263
TABLE 341 ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 264
TABLE 342 ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 264
TABLE 343 ASIA PACIFIC: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 264
TABLE 344 ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 265
TABLE 345 CHINA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 266
TABLE 346 CHINA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 266
TABLE 347 CHINA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 266
TABLE 348 CHINA: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 267
TABLE 349 CHINA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 267
TABLE 350 CHINA: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 267
TABLE 351 CHINA: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 268
TABLE 352 CHINA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 268
TABLE 353 JAPAN: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 269
TABLE 354 JAPAN: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 269
TABLE 355 JAPAN: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 270
TABLE 356 JAPAN: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 270
TABLE 357 JAPAN: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 270
TABLE 358 JAPAN: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 271
TABLE 359 JAPAN: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 271
TABLE 360 JAPAN: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 271
TABLE 361 INDIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 272
TABLE 362 INDIA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 273
TABLE 363 INDIA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 273
TABLE 364 INDIA: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 273
TABLE 365 INDIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 274
TABLE 366 INDIA: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 274
TABLE 367 INDIA: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 274
TABLE 368 INDIA: MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION 275
TABLE 369 AUSTRALIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 276
TABLE 370 AUSTRALIA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 276
TABLE 371 AUSTRALIA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 276
TABLE 372 AUSTRALIA: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 277
TABLE 373 AUSTRALIA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 277
TABLE 374 AUSTRALIA: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 277
TABLE 375 AUSTRALIA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 278
TABLE 376 AUSTRALIA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 278
TABLE 377 SOUTH KOREA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 279
TABLE 378 SOUTH KOREA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 279
TABLE 379 SOUTH KOREA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 279
TABLE 380 SOUTH KOREA: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 280
TABLE 381 SOUTH KOREA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 280
TABLE 382 SOUTH KOREA: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 280
TABLE 383 SOUTH KOREA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 281
TABLE 384 SOUTH KOREA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 281
TABLE 385 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 282
TABLE 386 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 282
TABLE 387 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 283
TABLE 388 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 283
TABLE 389 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 284
TABLE 390 REST OF ASIA PACIFIC: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 284
TABLE 391 REST OF ASIA PACIFIC: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 284
TABLE 392 REST OF ASIA PACIFIC: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 285
TABLE 393 LATIN AMERICA: MACROECONOMIC INDICATORS 286
TABLE 394 LATIN AMERICA: MICE MODEL MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 286
TABLE 395 LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 286
TABLE 396 LATIN AMERICA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 287
TABLE 397 LATIN AMERICA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 287
TABLE 398 LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 287
TABLE 399 LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 288
TABLE 400 LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 288
TABLE 401 LATIN AMERICA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 288
TABLE 402 LATIN AMERICA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 289
TABLE 403 BRAZIL: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 290
TABLE 404 BRAZIL: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 290
TABLE 405 BRAZIL: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 290
TABLE 406 BRAZIL: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 291
TABLE 407 BRAZIL: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 291
TABLE 408 BRAZIL: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291
TABLE 409 BRAZIL: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 292
TABLE 410 BRAZIL: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 292
TABLE 411 MEXICO: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 293
TABLE 412 MEXICO: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 293
TABLE 413 MEXICO: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 293
TABLE 414 MEXICO: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 294
TABLE 415 MEXICO: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 294
TABLE 416 MEXICO: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 294
TABLE 417 MEXICO: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 295
TABLE 418 MEXICO: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION 295
TABLE 419 REST OF LATIN AMERICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 296
TABLE 420 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 296
TABLE 421 REST OF LATIN AMERICA: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 297
TABLE 422 REST OF LATIN AMERICA: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 297
TABLE 423 REST OF LATIN AMERICA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 298
TABLE 424 REST OF LATIN AMERICA: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 298
TABLE 425 REST OF LATIN AMERICA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 298
TABLE 426 REST OF LATIN AMERICA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 299
TABLE 427 MIDDLE EAST: MACROECONOMIC INDICATORS 300
TABLE 428 MIDDLE EAST: MICE MODEL MARKET, BY REGION, 2023–2030 (USD MILLION) 300
TABLE 429 MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 300
TABLE 430 MIDDLE EAST: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 301
TABLE 431 MIDDLE EAST: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 301
TABLE 432 MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 301
TABLE 433 MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 302
TABLE 434 MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 302
TABLE 435 MIDDLE EAST: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 302
TABLE 436 MIDDLE EAST: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 303
TABLE 437 GCC COUNTRIES: MICE MODEL MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 303
TABLE 438 GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 304
TABLE 439 GCC COUNTRIES: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 304
TABLE 440 GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 304
TABLE 441 GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 305
TABLE 442 GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 305
TABLE 443 GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 305
TABLE 444 GCC COUNTRIES: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 306
TABLE 445 GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 306
TABLE 446 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 307
TABLE 447 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 307
TABLE 448 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 308
TABLE 449 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 308
TABLE 450 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY THERAPEUTIC AREA, 2023–2030 (USD MILLION) 309
TABLE 451 KINGDOM OF SAUDI ARABIA: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 309
TABLE 452 KINGDOM OF SAUDI ARABIA: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 309
TABLE 453 KINGDOM OF SAUDI ARABIA: MICE MODEL SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 310
TABLE 454 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 311
TABLE 455 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 311
TABLE 456 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 311
TABLE 457 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 312
TABLE 458 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 312
TABLE 459 UNITED ARAB EMIRATES: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 313
TABLE 460 UNITED ARAB EMIRATES: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 313
TABLE 461 UNITED ARAB EMIRATES: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 313
TABLE 462 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 314
TABLE 463 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 315
TABLE 464 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 315
TABLE 465 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 315
TABLE 466 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 316
TABLE 467 OTHER GCC COUNTRIES: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 316
TABLE 468 OTHER GCC COUNTRIES: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 316
TABLE 469 OTHER GCC COUNTRIES: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 317
TABLE 470 REST OF MIDDLE EAST: MICE MODEL MARKET, BY MODEL TYPE & SERVICE, 2023–2030 (USD MILLION) 318
TABLE 471 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TYPE,
2023–2030 (USD MILLION) 318
TABLE 472 REST OF MIDDLE EAST: MICE MODEL MARKET, BY SERVICE,
2023–2030 (USD MILLION) 318
TABLE 473 REST OF MIDDLE EAST: MICE MODEL MARKET, BY TECHNOLOGY,
2023–2030 (USD MILLION) 319
TABLE 474 REST OF MIDDLE EAST: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 319
TABLE 475 REST OF MIDDLE EAST: MICE MODEL MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 320
TABLE 476 REST OF MIDDLE EAST: MICE MODEL TYPE MARKET, BY END USER,
2023–2030 (USD MILLION) 320
TABLE 477 REST OF MIDDLE EAST: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 320
TABLE 478 MACROECONOMIC OUTLOOK FOR AFRICA 322
TABLE 479 AFRICA: MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2023–2030 (USD MILLION) 322
TABLE 480 AFRICA: MICE MODEL MARKET, BY TYPE, 2023–2030 (USD MILLION) 322
TABLE 481 AFRICA: MICE MODEL MARKET, BY SERVICE, 2023–2030 (USD MILLION) 323
TABLE 482 AFRICA: MICE MODEL MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 323
TABLE 483 AFRICA: MICE MODEL MARKET, BY THERAPEUTIC AREA,
2023–2030 (USD MILLION) 323
TABLE 484 AFRICA: MICE MODEL MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 324
TABLE 485 AFRICA: MICE MODEL TYPE MARKET, BY END USER, 2023–2030 (USD MILLION) 324
TABLE 486 AFRICA: MICE MODEL SERVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 324
TABLE 487 STRATEGIES ADOPTED BY KEY PLAYERS IN MICE MODEL MARKET, 2022−2025 326
TABLE 488 MICE MODEL MARKET: INTENSITY OF COMPETITIVE RIVALRY 329
TABLE 489 MICE MODEL MARKET: REGION FOOTPRINT 334
TABLE 490 MICE MODEL MARKET: MODEL TYPE & SERVICE FOOTPRINT 335
TABLE 491 MICE MODEL MARKET: APPLICATION FOOTPRINT 336
TABLE 492 MICE MODEL MARKET: TECHNOLOGY FOOTPRINT 337
TABLE 493 MICE MODEL MARKET: THERAPEUTIC AREA FOOTPRINT 338
TABLE 494 MICE MODEL MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 341
TABLE 495 MICE MODEL MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 342
TABLE 496 MICE MODEL MARKET: PRODUCT/SERVICE LAUNCHES,
JANUARY 2022−JUNE 2025 345
TABLE 497 MICE MODEL MARKET: DEALS, JANUARY 2022−JUNE 2025 345
TABLE 498 MICE MODEL MARKET: EXPANSIONS, JANUARY 2022−JUNE 2025 349
TABLE 499 MICE MODEL MARKET: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 351
TABLE 500 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 352
TABLE 501 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES OFFERED 353
TABLE 502 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2022−JUNE 2025 356
TABLE 503 CHARLES RIVER LABORATORIES: EXPANSIONS, JANUARY 2022−JUNE 2025 357
TABLE 504 CHARLES RIVER LABORATORIES: OTHER DEVELOPMENTS,
JANUARY 2022−JUNE 2025 358
TABLE 505 THE JACKSON LABORATORY: COMPANY OVERVIEW 359
TABLE 506 THE JACKSON LABORATORY: PRODUCTS/SERVICES OFFERED 360
TABLE 507 THE JACKSON LABORATORY: DEALS, JANUARY 2022−JUNE 2025 366
TABLE 508 THE JACKSON LABORATORY: EXPANSIONS, JANUARY 2022−JUNE 2025 367
TABLE 509 INOTIV: COMPANY OVERVIEW 369
TABLE 510 INOTIV: PRODUCTS/SERVICES OFFERED 370
TABLE 511 INOTIV: DEALS, JANUARY 2022−JUNE 2025 373
TABLE 512 INOTIV: EXPANSIONS, JANUARY 2022−JUNE 2025 374
TABLE 513 JSR CORPORATION: COMPANY OVERVIEW 375
TABLE 514 JSR CORPORATION: PRODUCTS/SERVICES OFFERED 376
TABLE 515 JSR CORPORATION: DEALS, JANUARY 2022−JUNE 2025 378
TABLE 516 JSR CORPORATION: EXPANSIONS, JANUARY 2022−JUNE 2025 378
TABLE 517 BIOCYTOGEN: COMPANY OVERVIEW 380
TABLE 518 BIOCYTOGEN: PRODUCTS/SERVICES OFFERED 381
TABLE 519 BIOCYTOGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2022−JUNE 2025 383
TABLE 520 BIOCYTOGEN: DEALS, JANUARY 2022−JUNE 2025 383
TABLE 521 BIOCYTOGEN: EXPANSIONS, JANUARY 2022−JUNE 2025 385
TABLE 522 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY OVERVIEW 387
TABLE 523 SHANGHAI MODEL ORGANISMS CENTER, INC.: PRODUCTS/SERVICES OFFERED 388
TABLE 524 SHANGHAI MODEL ORGANISMS CENTER, INC.: DEALS, JANUARY 2022−JUNE 2025 389
TABLE 525 TRANS GENIC INC.: COMPANY OVERVIEW 390
TABLE 526 TRANS GENIC, INC.: PRODUCTS/SERVICES OFFERED 391
TABLE 527 TRANS GENIC, INC.: DEALS, JANUARY 2022−JUNE 2025 392
TABLE 528 HARBOUR BIOMED: COMPANY OVERVIEW 393
TABLE 529 HARBOUR BIOMED: PRODUCTS/SERVICES OFFERED 394
TABLE 530 HARBOUR BIOMED: DEALS, JANUARY 2022−JUNE 2025 395
TABLE 531 HARBOUR BIOMED: OTHER DEVELOPMENTS, JANUARY 2022−JUNE 2025 397
TABLE 532 GENOWAY: COMPANY OVERVIEW 398
TABLE 533 GENOWAY: PRODUCTS/SERVICES OFFERED 399
TABLE 534 GENOWAY: DEALS, JANUARY 2022−JUNE 2025 401
TABLE 535 GEMPHARMATECH: COMPANY OVERVIEW 402
TABLE 536 GEMPHARMATECH: PRODUCTS/SERVICES OFFERED 403
TABLE 537 GEMPHARMATECH: PRODUCT/SERVICE LAUNCHES, JANUARY 2022−JUNE 2025 404
TABLE 538 GEMPHARMATECH: DEALS, JANUARY 2022−JUNE 2025 405
TABLE 539 GEMPHARMATECH: EXPANSIONS, JANUARY 2022−JUNE 2025 405
TABLE 540 CYAGEN: COMPANY OVERVIEW 406
TABLE 541 CYAGEN: PRODUCTS/SERVICES OFFERED 406
TABLE 542 CYAGEN: DEALS, JANUARY 2022−JUNE 2025 407
TABLE 543 OZGENE PTY LTD.: COMPANY OVERVIEW 408
TABLE 544 OZGENE PTY LTD.: PRODUCTS/SERVICES OFFERED 408
TABLE 545 OZGENE PTY. LTD: DEALS, JANUARY 2022−JUNE 2025 409
TABLE 546 TACONIC BIOSCIENCES, INC.: COMPANY OVERVIEW 410
TABLE 547 TACONIC BIOSCIENCES, INC.: PRODUCTS/SERVICES OFFERED 410
TABLE 548 TACONIC BIOSCIENCES, INC.: PRODUCT/SERVICE LAUNCHES,
JANUARY 2022−JUNE 2025 412
TABLE 549 TACONIC BIOSCIENCES, INC.: DEALS, JANUARY 2022−JUNE 2025 413
TABLE 550 TACONIC BIOSCIENCES, INC.: EXPANSIONS, JANUARY 2022−JUNE 2025 413
TABLE 551 TRANSCURE BIOSERVICES: COMPANY OVERVIEW 414
TABLE 552 TRANSCURE BIOSERVICES: PRODUCTS/SERVICES OFFERED 414
TABLE 553 TRANSCURE BIOSERVICES: DEALS, JANUARY 2022−JUNE 2025 415
TABLE 554 VIVO BIO TECH LTD.: COMPANY OVERVIEW 416
TABLE 555 VIVO BIO TECH LTD.: PRODUCTS/SERVICES OFFERED 417
TABLE 556 INGENIOUS TARGETING LABORATORY: COMPANY OVERVIEW 418
TABLE 557 INGENIOUS TARGETING LABORATORY: PRODUCTS/SERVICES OFFERED 418
TABLE 558 JANVIER LABS: COMPANY OVERVIEW 420
TABLE 559 JANVIER LABS: PRODUCTS/SERVICES OFFERED 420
TABLE 560 JANVIER LABS: DEALS, JANUARY 2022−JUNE 2025 423
TABLE 561 CHAMPIONS ONCOLOGY, INC.: COMPANY OVERVIEW 424
TABLE 562 CHAMPIONS ONCOLOGY, INC.: PRODUCTS OFFERED 425
TABLE 563 CHAMPIONS ONCOLOGY, INC.: DEALS, JANUARY 2022−JUNE 2025 425
TABLE 564 VITALSTAR BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW 426
TABLE 565 VITALSTAR BIOTECHNOLOGY CO., LTD.: PRODUCTS OFFERED 426
TABLE 566 ONCODESIGN SERVICES: COMPANY OVERVIEW 427
TABLE 567 CLEA JAPAN, INC.: COMPANY OVERVIEW 428
TABLE 568 APPLIED STEMCELL: COMPANY OVERVIEW 429
TABLE 569 CREATIVE ANIMODEL: COMPANY OVERVIEW 430
TABLE 570 JOINN LABORATORIES (CHINA) CO., LTD.: COMPANY OVERVIEW 431
TABLE 571 CREATIVE BIOLABS: COMPANY OVERVIEW 432
TABLE 572 CRESCENDO BIOLOGICS LIMITED: COMPANY OVERVIEW 433
TABLE 573 ARAGEN LIFE SCIENCES LTD.: BUSINESS OVERVIEW 434
TABLE 574 POLYGENE: BUSINESS OVERVIEW 435
TABLE 575 PHARMATEST: BUSINESS OVERVIEW 436
TABLE 576 MARSHALL BIORESOURCES: BUSINESS OVERVIEW 437
FIGURE 1 MICE MODEL MARKET SEGMENTATION 42
FIGURE 2 RESEARCH DESIGN 45
FIGURE 3 MICE MODEL MARKET: BREAKDOWN OF PRIMARIES 47
FIGURE 4 MICE MODEL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 47
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE
ANALYSIS-BASED ESTIMATION), 2024 48
FIGURE 6 ILLUSTRATIVE EXAMPLE OF CHARLES RIVER LABORATORIES:
REVENUE SHARE ANALYSIS (2024) 49
FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 50
FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 50
FIGURE 9 MICE MODEL MARKET: CAGR PROJECTIONS 52
FIGURE 10 DATA TRIANGULATION METHODOLOGY 53
FIGURE 11 MICE MODEL MARKET, BY MODEL TYPE & SERVICE,
2025 VS. 2030 (USD MILLION) 56
FIGURE 12 MICE MODEL MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 57
FIGURE 13 MICE MODEL MARKET, BY THERAPEUTIC AREA, 2025 VS. 2030 (USD MILLION) 57
FIGURE 14 MICE MODEL MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 58
FIGURE 15 GEOGRAPHIC SNAPSHOT OF MICE MODEL MARKET 59
FIGURE 16 RISING DEMAND FOR MOUSE CLINICAL TRIALS TO PROPEL MARKET 60
FIGURE 17 MODEL TYPE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 61
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 61
FIGURE 19 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 62
FIGURE 20 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE MARKET DURING FORECAST PERIOD 62
FIGURE 21 MICE MODEL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 63
FIGURE 22 MICE MODEL MARKET: VALUE CHAIN ANALYSIS 75
FIGURE 23 AVERAGE SELLING PRICE TREND OF MODEL TYPES, BY KEY PLAYER,
2022–2024 (USD) 77
FIGURE 24 AVERAGE SELLING PRICE OF MODEL TYPES, BY REGION (USD) 78
FIGURE 25 MICE MODEL MARKET: ECOSYSTEM ANALYSIS 79
FIGURE 26 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86
FIGURE 27 PATENT APPLICATIONS IN MICE MODEL MARKET,
JANUARY 2014−DECEMBER 2024 88
FIGURE 28 MICE MODEL MARKET: PORTER’S FIVE FORCES ANALYSIS 103
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICE MODEL MARKET 105
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 106
FIGURE 31 INVESTMENT & FUNDING SCENARIO, 2022–2025 107
FIGURE 32 AI-USE CASES IN MICE MODEL MARKET 108
FIGURE 33 NORTH AMERICA: MICE MODEL MARKET SNAPSHOT 225
FIGURE 34 ASIA PACIFIC: MICE MODEL MARKET SNAPSHOT 261
FIGURE 35 REVENUE SHARE ANALYSIS FOR KEY COMPANIES, 2022–2024 (USD MILLION) 328
FIGURE 36 MICE MODEL MARKET SHARE ANALYSIS OF KEY PLAYERS (2024) 329
FIGURE 37 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS) 2024, 332
FIGURE 38 MICE MODEL MARKET: COMPANY FOOTPRINT 333
FIGURE 39 MICE MODEL MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 340
FIGURE 40 EV/EBITDA OF KEY VENDORS 343
FIGURE 41 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK
BETA OF KEY VENDORS 343
FIGURE 42 MICE MODEL MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 344
FIGURE 43 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 353
FIGURE 44 THE JACKSON LABORATORY: COMPANY SNAPSHOT (2024) 360
FIGURE 45 INOTIV: COMPANY SNAPSHOT (2024) 370
FIGURE 46 JSR CORPORATION: COMPANY SNAPSHOT (2023) 376
FIGURE 47 BIOCYTOGEN: COMPANY SNAPSHOT (2024) 381
FIGURE 48 SHANGHAI MODEL ORGANISMS CENTER, INC.: COMPANY SNAPSHOT (2024) 387
FIGURE 49 TRANS GENIC INC.: COMPANY SNAPSHOT (2024) 391
FIGURE 50 HARBOUR BIOMED: COMPANY SNAPSHOT (2024) 394
FIGURE 51 GENOWAY: COMPANY SNAPSHOT (2024) 398
FIGURE 52 GEMPHARMATECH: COMPANY SNAPSHOT (2024) 402
FIGURE 53 VIVO BIO TECH LTD.: COMPANY SNAPSHOT (2023) 416
FIGURE 54 CHAMPIONS ONCOLOGY, INC.: COMPANY SNAPSHOT (2023) 424